Peptide record

TPDB07321

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07321
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 13-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FMPILSCSRFKRC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C70H114N20O16S3
ANDEQGHTWYV
RCFS
1587.98
10.12
3
0
5
+3
1.65
0.362
60.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.08
4
Residue Composition
number
0
A
2
R
0
N
0
D
2
C
0
E
0
Q
0
G
0
H
1
I
1
L
1
K
1
M
2
F
1
P
2
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 1 K: 1 M: 1 F: 2 P: 1 S: 2 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
13 reviewed residue count
C70H114N20O16S3 sequence-only estimate (linear, free termini)
1587.98 sequence-only estimate (linear, free termini)
10.12 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
1.65 sequence-only estimate (linear, free termini)
0.362 sequence-only estimate (linear, free termini)
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4.7 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml)
Evidence 2 Activity

Activity

MIC
Antibacterial
9.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 3 Activity

Activity

MIC
Antibacterial
37.5 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 4 Activity

Activity

MIC
Antibacterial
1.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

nst E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 5 Activity

Activity

MIC
Antifungal
4.7 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml)
Evidence 6 Activity

Activity

MIC
Antifungal
9.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 7 Activity

Activity

MIC
Antifungal
37.5 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 8 Activity

Activity

MIC
Antifungal
1.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

nst E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 9 Activity

Activity

MIC
Antiparasitic
4.7 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml)
Evidence 10 Activity

Activity

MIC
Antiparasitic
9.4 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 11 Activity

Activity

MIC
Antiparasitic
37.5 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 12 Activity

Activity

MIC
Antiparasitic
1.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

nst E. coli (MIC 4.7 ug/ml), S. aureus (MIC 9.4 ug/ml), B. subtilis (MIC 37.5 ug/ml), and C. albicans (MIC 1.1 ug/ml). Aslo histamine release.
Evidence 13 Activity

Activity

0% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 14 Activity

Activity

0% degranulation
Toxicity
50 µg/mL
Cytotoxic
0% degranulation | 50 | µg/mL | target cell: Human mast cells

Target

Human mast cells

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 15 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:17272268] It has no hemolytic activity against rabbit red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Mol Cell Proteomics. 2007 May 6(5):882-894.